Anika Therapeutics, Inc.
General ticker "ANIK" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $185.7M (TTM average)
Anika Therapeutics, Inc. does not follow the US Stock Market performance with the rate: -23.4%.
Estimated limits based on current volatility of 4.3%: low 14.00$, high 15.27$
Factors to consider:
- Total employees count: 288 (-18.2%) as of 2024
- US accounted for 68.8% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Dependence on sales growth, Supply chain disruptions, Operational and conduct risks, Labor/talent shortage/retention, Strategic risks and growth management
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [7.34$, 14.00$]
- 2026-12-31 to 2027-12-31 estimated range: [8.35$, 15.38$]
Financial Metrics affecting the ANIK estimates:
- Positive: with PPE of 59.4 at the end of fiscal year the price was low
- Negative: negative Operating income
- Positive: 6.64 < Operating cash flow per share per price, % of 8.21
- Positive: Shareholder equity ratio, % of 75.40 > 64.29
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of -0.29 > -0.63
- Positive: Inventory ratio change, % of -2.29 <= -0.75
Short-term ANIK quotes
Long-term ANIK plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $120.79MM | $119.91MM | $112.82MM |
| Operating Expenses | $119.95MM | $125.01MM | $123.87MM |
| Operating Income | $0.84MM | $-5.10MM | $-11.05MM |
| Non-Operating Income | $2.31MM | $2.34MM | $1.74MM |
| R&D Expense | $21.76MM | $25.54MM | $25.77MM |
| Income(Loss) | $3.16MM | $-2.76MM | $-9.31MM |
| Taxes | $6.59MM | $6.06MM | $0.67MM |
| Other Income(Loss) | $-79.23MM | $-47.56MM | $0.00MM |
| Profit(Loss)* | $-161.90MM | $-103.94MM | $-10.88MM |
| Stockholders Equity | $212.26MM | $153.99MM | $143.47MM |
| Inventory | $24.43MM | $23.81MM | $18.79MM |
| Assets | $270.63MM | $202.74MM | $190.27MM |
| Operating Cash Flow | $-1.79MM | $5.40MM | $11.19MM |
| Capital expenditure | $5.43MM | $7.73MM | $6.83MM |
| Investing Cash Flow | $-5.43MM | $-8.33MM | $-0.40MM |
| Financing Cash Flow | $-6.32MM | $-12.73MM | $-10.55MM |
| Earnings Per Share** | $-11.05 | $-7.06 | $-0.76 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.